Acasă › Cancer ovarian › Utah › Salt Lake City
Studii clinice pentru Cancer ovarian în Salt Lake City, UT
19 studii pentru Cancer ovarian caută participanți în și în jurul orașului Salt Lake City (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
În curs de recrutareFaza 2/3
- Huntsman Cancer Institute/University of Utah, Salt Lake City
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
În curs de recrutareFaza 1
- University of Utah - Huntsman Cancer Institute, Salt Lake City
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
În curs de recrutareFaza 1
- Intermountain Health, Salt Lake City
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
În curs de recrutareFaza 3
- Huntsman Cancer Institute, Salt Lake City
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
În curs de recrutareFaza 2
- Utah Cancer Specialists, Salt Lake City
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
În curs de recrutareStudiu observațional
- Utah Cancer Specialists, Salt Lake City
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
În curs de recrutareFaza 1
- Intermountain/LDS Hospital Ph 1 Research Program, Salt Lake City
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
În curs de recrutareFaza 1
- START Mountain, Salt Lake City
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
În curs de recrutare
- University of Utah Sugarhouse Health Center, Salt Lake City
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
În curs de recrutareFaza 3
- University of Utah Sugarhouse Health Center, Salt Lake City
- Huntsman Cancer Institute/University of Utah, Salt Lake City
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
În curs de recrutareFaza 1/2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 1/2
- Utah Cancer Specialists, Salt Lake City
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
În curs de recrutareFaza 3
- Utah Cancer Specialists Network, Salt Lake City
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
În curs de recrutareFaza 1/2
- Huntsman Cancer Institute, Salt Lake City
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
În curs de recrutare
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
The SENTRY Study: Testing Whether Changes in Platelet RNA Enhance the Early Diagnosis of Ovarian Cancer
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Huntsman Cancer Institute, Salt Lake City
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
În curs de recrutareFaza 1/2
- START Center for Cancer Care - Mountain Region, Salt Lake City
A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers
În curs de recrutareFaza 1
- LDS Hospital, Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
În curs de recrutareStudiu observațional
- Massive Bio SYNERGY-AI site, Salt Lake City
Studii pentru Cancer ovarian în alte orașe
- Houston, TX89 studii
- New York City, NY69 studii
- Boston, MA61 studii
- Los Angeles, CA50 studii
- Nashville, TN49 studii
- Arlington, VA46 studii
- Philadelphia, PA44 studii
- Columbus, OH39 studii
- St. Louis, MO38 studii
- Chicago, IL36 studii
- San Antonio, TX31 studii
- Cleveland, OH30 studii
Alte studii în Salt Lake City
- Cancer pulmonar cu celule non-pătrate31 studii
- Cancer (toate tipurile)27 studii
- Cancer de sân27 studii
- Cancer colorectal22 studii
- Cancer pulmonar21 studii
- Melanom21 studii
- Mielom multiplu21 studii
- Cancer metastatic20 studii
- Obezitate18 studii
- Leucemie mieloasă acută17 studii
- Insuficiență cardiacă17 studii
- Cancer de prostată15 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.